Turning Point Therapeutics Reports First-Quarter Financial Results, Provides Update on Operations and COVID-19 Response

NEXT STORY
Genespire and SR-Tiget announce strategic alliance for the development of transformative gene therapies for genetic diseases and disclose collaboration focus
PREV STORY
Sun BioPharma, Inc. Provides a Business Update and Reports Q1 2020 Financial Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Replimune Provides Updated Data from RP2 at the 2021 Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting

author_avatar
NASDAQ Market News

Beyond Air® Reports Financial Results for Third Quarter of Fiscal Year 2021 and Provides Business Update

author_avatar
NASDAQ Market News

Kleo Pharmaceuticals Presents Preclinical Data on KPMW135, a Novel CD3 x CD20 Bispecific Version of Rituximab, Showing Increased Anti-Tumor Activity Compared to Rituximab, at The 62nd Annual American Society of Hematology (ASH) Meeting

author_avatar
NASDAQ Market News